NFKB1 and non-small cell lung carcinoma: The NF-κB TFs and their immediate upstream signalling components are aberrantly expressed and/or activated in inflammatory lung diseases and NSCLC and have been implicated in the unfavourable prognosis of patient survival [7,24].